Clinical Trial Update: HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan

View source ↗

Summary

This clinical trial update examines the frequency of HLA-A*02:01 and NY-ESO-1 expression in cancer patients in Taiwan and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: PharmaEssentia | Conditions: Solid Tumor Malignancy | Status: RECRUITING